NNH: Sales growth strong outside Nordics, but margins and profits pressured by costs and investments

About this update from New Nordic Healthbrands Ab

Net sales grew 8.4% in Q2 and 5.8% in H1 2024, with strong gains in Europe, North America, and Asia, but declines in the Nordics. Gross margin slipped, and profitability remained negative, impacted by higher costs and one-off investments. Management expects improved results in H2.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for New Nordic Healthbrands Ab